Global Apixaban {Eliquis} Market is estimated to be US$ 18.85 billion by 2030 with a CAGR of 7.5% during the forecast period

Download Sample

Published Date: August 2023

The Global Apixaban {Eliquis} Market accounted for US$ 9.17 billion in 2020 and is estimated to be US$ 18.85 billion by 2030 and is anticipated to register a CAGR of 7.5%. Apixaban is an anticoagulant that has been approved by the FDA for the treatment of venous thromboembolic events (blood clots) that occur within a vein. It's used to replace warfarin and doesn't require any blood tests or dietary restrictions. VTEs can occur without warning signs or symptoms, and they can go untreated and unrecognized by healthcare providers. Symptoms of pulmonary embolism (PE) include leg pain, ankle or foot swelling, redness or apparent discoloration, fast breathing, chest pain, and other symptoms. Nausea and bleeding are both common side effects.

The report " Global Apixaban {Eliquis} Market, By Dosage form (Tablets and Capsule), By Distribution channel (Hospital, Online pharmacies, Retail pharmacies and Clinics), By Route of administration (Oral and Injectable), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Key Highlights:

In October 2019, The FDA announced the approval of the additional disease indication of the prevention of venous thromboembolism in hospitalized acutely ill medical patients at risk for thromboembolic complications but not at high risk of bleeding for janssen pharmaceuticals Inc. products offering of Rivaroxaban {Xarelto}.
In February 2019, Novartis AG and Blackstones lifeSciences announced the launch if Anthos therapeutics for the development of cardiovascular drugs and its pipeline includes an anticoagulant.

Analyst View:

As the prevalence of venous thromboembolism-related illnesses increases, the market for apixaban is expected to grow. Furthermore, as the number of therapeutic indications for apixaban increases, the market for the drug is expected to grow. Eliquis, for example, was approved by the US Food and Drug Administration in 2014 for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as the decrease of the risk of recurrent PE and DVT following initial treatment. Side effects such as an increased risk of thrombotic events upon premature withdrawal and bleeding are expected to stymie apixaban's adoption. As a result, the market's growth is expected to suffer as a result.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Apixaban {Eliquis} Market, By Dosage form (Tablets and Capsule), By Distribution channel (Hospital, Online pharmacies, Retail pharmacies and Clinics), By Route of administration (Oral and Injectable), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Key Market Insights from the report:

The Global Apixaban {Eliquis} Market accounted for US$ 9.17 billion in 2020 and is estimated to be US$ 18.85 billion by 2030 and is anticipated to register a CAGR of 7.5%. The Global Apixaban {Eliquis} Market is segmented based on the dosage form, distribution channel, route of administration and region.

By Dosage form, the Global Apixaban {Eliquis} Market is segmented into Tablets and Capsules.
By Distribution channel, the market is segmented in Hospital, Retail pharmacies,Online pharmacies and Clinics.
By Route of administration, the Global Apixaban {Eliquis} Market is segmented into
Oral and Injectable.
By Region, the Global Apixaban {Eliquis} Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global Apixaban {Eliquis} market.

Competitive Landscape:

The key players operating in the global Apixaban {Eliquis} market includes Abbott, Roche, Bristol-Myers Squibb, Siemens, Portola Pharmaceuticals, C. H. Boehringer Sohn, Pfizer, CoaguSense and Alere.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period